{"DataElement":{"publicId":"3225971","version":"1","preferredName":"Neuroglial Tumor Oligodendroglioma Cellular Differentiation Percentage Value","preferredDefinition":"Numeric value for result of tumor cells showing oligodendroglial differentiation expressed in percent.","longName":"3225968v1.0:3225970v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3225968","version":"1","preferredName":"Neuroglial Tumor Cellular Differentiation","preferredDefinition":"A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells).  Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas.  Tumors that arise from oligodendrocytes are called oligodendroglial tumors.  Tumors that arise from ependymal cells are called ependymomas. -- 2004_In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.","longName":"3139372v1.0:2200802v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3139372","version":"1","preferredName":"Neuroglial Tumor","preferredDefinition":"A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells).  Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas.  Tumors that arise from oligodendrocytes are called oligodendroglial tumors.  Tumors that arise from ependymal cells are called ependymomas. -- 2004","longName":"C3059","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glioma","conceptCode":"C3059","definition":"A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells). Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas. Tumors that arise from oligodendrocytes are called oligodendroglial tumors. Tumors that arise from ependymal cells are called ependymomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B3E23B-80BF-48C9-E040-BB89AD435F9F","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"ONEDATA","dateModified":"2010-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2200802","version":"1","preferredName":"Differentiation","preferredDefinition":"In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.","longName":"C18314","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cellular Differentiation","conceptCode":"C18314","definition":"In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F169098A-EBC6-306E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-08","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A046ADA8-C8D3-E433-E040-BB89AD431137","latestVersionIndicator":"Yes","beginDate":"2011-04-06","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of L.Dillon 4/2011","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3225970","version":"1","preferredName":"Oligodendroglioma Cellular Differentiation Percentage Value","preferredDefinition":"A well-differentiated (WHO grade II), diffusely infiltrating neuroglial tumor of adults, typically located in the cerebral hemispheres.  It is composed predominantly of cells which morphologically resemble oligodendroglia. The neoplastic cells have rounded homogeneous nuclei and, on paraffin sections, a swollen, clear cytoplasm ('honeycomb' appearance).  It generally recurs locally, with median post-operative survival times ranging from 3 to 5 years for patients with all histological grades. (Adapted from WHO.)_In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably._Percentage; a fraction or ratio with 100 understood as the denominator._A numerical quantity measured or assigned or computed.","longName":"3225970v1.0","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":"1","maxLength":"3","minValue":"0","maxValue":"100","decimalPlace":"0","format":"%","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3225969","version":"1","preferredName":"Oligodendroglioma Cellular Differentiation Percentage Value","preferredDefinition":"A well-differentiated (WHO grade II), diffusely infiltrating neuroglial tumor of adults, typically located in the cerebral hemispheres.  It is composed predominantly of cells which morphologically resemble oligodendroglia. The neoplastic cells have rounded homogeneous nuclei and, on paraffin sections, a swollen, clear cytoplasm ('honeycomb' appearance).  It generally recurs locally, with median post-operative survival times ranging from 3 to 5 years for patients with all histological grades. (Adapted from WHO.):In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.:Percentage; a fraction or ratio with 100 understood as the denominator.:A numerical quantity measured or assigned or computed.","longName":"C3288:C18314:C25613:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oligodendroglioma","conceptCode":"C3288","definition":"A well-differentiated (WHO grade 2), diffusely infiltrating neuroglial tumor, typically located in the cerebral hemispheres.  It is composed predominantly of cells which morphologically resemble oligodendroglia. The neoplastic cells have rounded homogeneous nuclei and, on paraffin sections, a swollen, clear cytoplasm ('honeycomb' appearance). (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Cellular Differentiation","conceptCode":"C18314","definition":"In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A046ADA8-C8EA-E433-E040-BB89AD431137","latestVersionIndicator":"Yes","beginDate":"2011-04-06","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-06","modifiedBy":"ONEDATA","dateModified":"2011-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A046ADA8-C8FB-E433-E040-BB89AD431137","latestVersionIndicator":"Yes","beginDate":"2011-04-06","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-06","modifiedBy":"WHITES","dateModified":"2011-04-18","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of L.Dillon 4/2011","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"% Tumor cells showing Oligode","type":"Preferred Question Text","description":"% Tumor cells showing Oligodendroglial Differentiation","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A046ADA8-C917-E433-E040-BB89AD431137","latestVersionIndicator":"Yes","beginDate":"2011-04-06","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-06","modifiedBy":"TSESU","dateModified":"2018-07-18","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of L.Dillon 4/2011 Modified definition - moved system-generated definition to alternate definition and replaced primary definition with human readable format approved by TCGA/J.Demchok  mc 8/11/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}